Atlas FDA

BINDING SITE BINDAZYME ANTI-GBM EIA DIAGNOSTIC TEST KIT

FDA 510(k) clearance K984619 · decided 1999-02-23

Clearance details

K-number
K984619
Device name
BINDING SITE BINDAZYME ANTI-GBM EIA DIAGNOSTIC TEST KIT
Applicant
The Binding Site, Ltd.
Decision
Substantially Equivalent
Date received
1998-12-29
Decision date
1999-02-23
Days to decision
56 days
Clearance type
Traditional
Product code
MVJ
Device class
2
Regulation number
866.5660
Medical specialty
Immunology
Advisory committee
Immunology
Location
Santa Monica, CA, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch The Binding Site

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
ATHENA MULTI-LYTE GBM TEST SYSTEM (K071219)Zeus Scientific, Inc.2007-12-06
BIOPLEX VASCULITIS KIT (K072358)Bio-Rad Laboratories2007-10-31
PHASE II GBM IGG ANTIBODY EIA TEST (K011348)Scimedx Corp.2001-06-25
AUTOSTAT II ANTI-GBM ELISA, HY.TEC ANTI-GMB ELISA (K991890)Cogent Diagnotics , Ltd.1999-08-09
QUANTA LITE GBM ELISA (K984336)Inova Diagnostics, Inc.1999-02-08

Recalls involving this device

No recalls on record reference this clearance.